Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome

J Neurol Neurosurg Psychiatry. 1985 Jun;48(6):501-5. doi: 10.1136/jnnp.48.6.501.

Abstract

Peripheral blood T cell subsets were measured using monoclonal antibodies and a fluorescence activated cell sorter in 15 untreated patients with Lambert-Eaton myasthenic syndrome (nine with small cell carcinoma, one undifferentiated epithelial tumour (ca-LEMS], five with no demonstrable tumour (non-ca-LEMS), 10 age-matched healthy controls and 10 patients with small cell carcinoma without neurological disease. OKT8+ (suppressor/cytotoxic) T cells were significantly decreased in ca-LEMS compared with non-ca LEMS (p less than 0.001) ca-controls (p less than 0.01) and healthy controls (p less than 0.001). In one patient depressed OKT8+ T cells antedated clinically evident tumour by five months. OKT3+ (total) and OKT4+ (helper) T cells were similar in ca-LEMS, non-ca LEMS and controls. The mechanism underlying the loss of circulating OKT8+ T cells in ca-LEMS is unknown, but these changes may help to predict the presence of carcinoma in this disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal
  • Carcinoma, Bronchogenic / blood*
  • Carcinoma, Small Cell / blood*
  • Female
  • Humans
  • Leukocyte Count
  • Lung Neoplasms / blood*
  • Male
  • Middle Aged
  • Muscular Diseases / blood*
  • Syndrome
  • T-Lymphocytes*

Substances

  • Antibodies, Monoclonal